XThis page contains elements that are not optimised for mobile viewing. Click the link below to view the page in desktop mode.
Desktop mode

This page is not available in English


Click here to see the Danish page 'Gigtmedicinen Xeljanz skal bruges med forsigtighed til patienter med høj risiko for blodpropper' Go to English frontpage